Ruibai Wang

757 total citations
26 papers, 565 citations indexed

About

Ruibai Wang is a scholar working on Endocrinology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Ruibai Wang has authored 26 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, 9 papers in Molecular Medicine and 8 papers in Infectious Diseases. Recurrent topics in Ruibai Wang's work include Vibrio bacteria research studies (13 papers), Antibiotic Resistance in Bacteria (9 papers) and Salmonella and Campylobacter epidemiology (8 papers). Ruibai Wang is often cited by papers focused on Vibrio bacteria research studies (13 papers), Antibiotic Resistance in Bacteria (9 papers) and Salmonella and Campylobacter epidemiology (8 papers). Ruibai Wang collaborates with scholars based in China, Switzerland and Germany. Ruibai Wang's co-authors include Biao Kan, Kanglin Wan, Jie Li, Junjie Yue, Dong Yu, Haican Liu, Jing Lou, Xiuqin Zhao, Fang Liu and Fanqiang Bu and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ruibai Wang

25 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruibai Wang China 14 217 147 146 125 100 26 565
Reza Ranjbar Iran 15 166 0.8× 226 1.5× 185 1.3× 100 0.8× 82 0.8× 32 664
Praveen Alamuri United States 13 183 0.8× 88 0.6× 293 2.0× 161 1.3× 116 1.2× 15 853
Mike S. Son United States 13 246 1.1× 206 1.4× 422 2.9× 106 0.8× 66 0.7× 21 805
José Luis Insua United Kingdom 8 158 0.7× 353 2.4× 192 1.3× 86 0.7× 95 0.9× 10 627
Bei Li China 13 143 0.7× 241 1.6× 228 1.6× 69 0.6× 114 1.1× 32 723
Arindam Mitra United States 13 131 0.6× 57 0.4× 158 1.1× 60 0.5× 48 0.5× 25 445
Thomas P. Griener Canada 13 220 1.0× 46 0.3× 221 1.5× 63 0.5× 102 1.0× 25 673
John R. Brannon United States 14 158 0.7× 119 0.8× 221 1.5× 40 0.3× 122 1.2× 17 506
Behrooz Sadeghi Kalani Iran 14 91 0.4× 90 0.6× 222 1.5× 68 0.5× 50 0.5× 60 520
Anne Doléans-Jordheim France 15 110 0.5× 156 1.1× 293 2.0× 34 0.3× 63 0.6× 28 564

Countries citing papers authored by Ruibai Wang

Since Specialization
Citations

This map shows the geographic impact of Ruibai Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruibai Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruibai Wang more than expected).

Fields of papers citing papers by Ruibai Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruibai Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruibai Wang. The network helps show where Ruibai Wang may publish in the future.

Co-authorship network of co-authors of Ruibai Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruibai Wang. A scholar is included among the top collaborators of Ruibai Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruibai Wang. Ruibai Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Bo, et al.. (2025). Stenotrophomonas tuberculopleuritidis sp. nov., a novel pathogenic Stenotrophomonas species isolated from tuberculous pleurisy patient. Frontiers in Cellular and Infection Microbiology. 15. 1629703–1629703.
2.
Xu, Da, et al.. (2024). A novel pathogenic species of genus Stenotrophomonas: Stenotrophomonas pigmentata sp. nov. Frontiers in Cellular and Infection Microbiology. 14. 1410385–1410385. 6 indexed citations
3.
Zhao, Xiuqin, et al.. (2023). A novel multistage antigens ERA005f confer protection against Mycobacterium tuberculosis by driving Th-1 and Th-17 type T cell immune responses. Frontiers in Immunology. 14. 1276887–1276887. 1 indexed citations
4.
Wang, Ruibai, et al.. (2022). Deterioration of Cycloserine in Drug Susceptibility Testing of Mycobacterium. SHILAP Revista de lepidopterología. 2 indexed citations
5.
Jiang, Yi, Xiangfeng Dou, Li Wan, et al.. (2020). Epidemiological characteristics and trends of notifiable infectious diseases in China from 1986 to 2016. Journal of Global Health. 10(2). 20803–20803. 34 indexed citations
6.
Zhou, Lei, Tongyang Xiao, Machao Li, et al.. (2019). A New Single Gene Differential Biomarker for Mycobacterium tuberculosis Complex and Non-tuberculosis Mycobacteria. Frontiers in Microbiology. 10. 1887–1887. 17 indexed citations
7.
Li, Guilian, Yi Jiang, Haican Liu, et al.. (2019). Synergistic activities of clofazimine with moxifloxacin or capreomycin against Mycobacterium tuberculosis in China. International Journal of Antimicrobial Agents. 54(5). 642–646. 9 indexed citations
8.
Wang, Ruibai, Jing Lou, & Jie Li. (2019). A mobile restriction modification system consisting of methylases on the IncA/C plasmid. Mobile DNA. 10(1). 26–26. 12 indexed citations
9.
Li, Chao, Guilian Li, Shuangjun Li, et al.. (2017). [A preliminary study on the molecular characteristics of D-cycloserine resistance of Mycobacterium tuberculosis].. PubMed. 38(2). 240–243. 1 indexed citations
10.
Wang, Ruibai, Haican Liu, Xiuqin Zhao, Jie Li, & Kanglin Wan. (2017). IncA/C plasmids conferring high azithromycin resistance in vibrio cholerae. International Journal of Antimicrobial Agents. 51(1). 140–144. 19 indexed citations
11.
Wang, Ruibai, Jie Li, & Biao Kan. (2016). Sequences of a co-existing SXT element, a chromosomal integron (CI) and an IncA/C plasmid and their roles in multidrug resistance in a Vibrio cholerae O1 El Tor strain. International Journal of Antimicrobial Agents. 48(3). 305–309. 12 indexed citations
12.
Wang, Ruibai, Dong Yu, Junjie Yue, & Biao Kan. (2016). Variations in SXT elements in epidemic Vibrio cholerae O1 El Tor strains in China. Scientific Reports. 6(1). 22733–22733. 43 indexed citations
13.
Wang, Ruibai, Dong Yu, Lianhui Zhu, et al.. (2014). IncA/C plasmids harboured in serious multidrug-resistant Vibrio cholerae serogroup O139 strains in China. International Journal of Antimicrobial Agents. 45(3). 249–254. 17 indexed citations
14.
Li, Fengjuan, Wenqing Wang, Zhaoqin Zhu, et al.. (2014). Distribution, virulence-associated genes and antimicrobial resistance of Aeromonas isolates from diarrheal patients and water, China. Journal of Infection. 70(6). 600–608. 48 indexed citations
15.
Wang, Qiu‐Ya, Biao Kan, & Ruibai Wang. (2013). Isolation and Characterization of the New Mosaic Filamentous Phage VFJ Φ of Vibrio cholerae. PLoS ONE. 8(8). e70934–e70934. 13 indexed citations
16.
Wang, Ruibai, Jing Lou, Jie Liu, et al.. (2012). Antibiotic resistance of Vibrio cholerae O1 El Tor strains from the seventh pandemic in China, 1961–2010. International Journal of Antimicrobial Agents. 40(4). 361–364. 23 indexed citations
17.
Wang, Ruibai, Haijian Zhou, Yuelan Wang, et al.. (2011). Characters of homogentisate oxygenase gene mutation and high clonality of the natural pigment-producing Vibrio choleraestrains. BMC Microbiology. 11(1). 109–109. 16 indexed citations
18.
19.
Kan, Biao, Monika Schmid, Weili Liang, et al.. (2004). Proteome comparison of Vibrio cholerae cultured in aerobic and anaerobic conditions. PROTEOMICS. 4(10). 3061–3067. 33 indexed citations
20.
Xu, Jing, Yanpeng Ding, Ruibai Wang, et al.. (2003). Molecular Epidemiology of Vibrio cholerae O139 in China: Polymorphism of Ribotypes and CTX Elements. Journal of Clinical Microbiology. 41(6). 2306–2310. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reza Ranjbar Breakdown of academic impact, for papers by Praveen Alamuri Breakdown of academic impact, for papers by Mike S. Son Breakdown of academic impact, for papers by José Luis Insua Breakdown of academic impact, for papers by Bei Li Breakdown of academic impact, for papers by Arindam Mitra Breakdown of academic impact, for papers by Thomas P. Griener Breakdown of academic impact, for papers by John R. Brannon Breakdown of academic impact, for papers by Behrooz Sadeghi Kalani Breakdown of academic impact, for papers by Anne Doléans-Jordheim
Rankless by CCL
2026